CONTACT AND PERSONAL INFORMATION

First Name: Félix

Last Name: Guerrero-Ramos

Degree: MD PhD FEBU

Spanish ID card: 75253984-P

Madrid Medical Council ID: 282863614

Primary Office:

Hospital Universitario 12 de Octubre

Dept of Urology

Avda. Córdoba s/n

28041 Madrid (Spain)

CURRICULUM VITAE

1. Education:

• Medicine Degree. “School of Medicine – Universidad Autónoma de Madrid”, 2002-2008
• Urology Residency at Hospital Universitario 12 de Octubre, Madrid (2009-2014).
• Doctorate Program Initiation Project: Percutaneous kidney biopsy using 16 Gauge needle: a safe technique? “School of Medicine – Universidad Complutense de Madrid”, June 2011
• Experimental surgery stay on urologic laparoscopy (Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain), including nephrectomies and prostatectomies in animal patterns (2011 and 2016)
• Postgraduate in Investigation, Publication and Scientific Communication in Men’s Health, Universitat de Barcelona, 2012-2013
• Observership at University College of London Hospital on focal therapy for prostate cancer (Prof. Mark Emberton) and reconstructive urology (Prof. Suks Minhas), March 2013 – April 2013
• Fellowship of the European Board of Urology (Brussels, June 2014)
• PhD degree with a distinction “cum laude” given unanimously for my doctoral thesis entitled “Comparative analysis of surgical complications in a program of uncontrolled DCD kidney donation under normothermic preservation”: Doctorate Program, Department of Surgery, “School of Medicine – Universidad Complutense de Madrid” (December 2015)
• STEPS (Sessions To Evaluate ProgresS in the management of urological cancers) participant at ESOU meeting in Madrid, January 2022.
• 211 CME Credits

2. Languages:

• English: Highest Grade by Spanish Official Language School (2002) [License of qualifications to teach English as a foreign language in Spain]
• French: Highest Grade by Spanish Official Language School (2002) [License of qualifications to teach French as a foreign language in Spain]

3. Employment Experience:

• May 2014 – now: staff urologist at Hospital Universitario 12 de Octubre, Madrid, member of the Oncological Urology Unit.
• January 2018 – now: head of the Bladder Cancer Unit at the Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain. Head of the Department of Urology: Dr. Alfredo Rodríguez-Antolín.
• January 2019 – now: head of the Oncological Urology Unit at HM Montepríncipe, Puerta del Sur & Sanchinarro private Hospital Group in Madrid, Spain. Head of the Department of Urology: Dr. Javier Romero-Otero.

4. Teaching experience:

• 2010 – now: Honorary Teaching Collaborator of Urology at “Department of Surgery I” of Universidad Complutense de Madrid.
• May 2014 – now: Lecturer at the Childcare Course for Primary Care Physicians, organized by the Spanish Society of Childcare.
• 2020 – now: Adjunct Professor of Urology at the School of Medicine of San Pablo CEU University.
• Lecturer at “Urology update for Primary Care” course (Madrid, 2016)
• Academic director for last-year Medicine students for graduation projects:
  • Comparative incidence of postoperative complications in DBD vs DCD kidney transplants (2016-2017)
  • Results of laparoscopic vs open nephroureterectomy in a tertiary university hospital, a justified controversy? (2016-2017)
  • Analysis of the implementation of a one-step hematuria clinic at a tertiary center Urology Department (2017-2018)
• Residency Training Programme Director at Hospital Universitario 12 de Octubre (2018-now)
• Currently mentoring 3 PhD projects on translational basic-clinic research on bladder cancer.
• Moderator for oral communications sessions at the Spanish Urological Association Congress every year.
• Invited lecturer for Plenary Sessions at the Spanish Urological Association Congress.
• Invited lecturer for bladder cancer talks, both in Spain and abroad.
• Invited for KOL talks and debates by different scientific associations.
• Reviewer for European Journal of Cancer Care and Journal of Clinical Urology (9 reviews).
• Advisory board: Johnson & Johnson, Taris Biomedical, AstraZeneca, Janssen, Combat Medical, Palex Medical.

5. Other professional activities:

• Author of the “Protocol for Primary Care referral in scrotal disease” at Hospital Universitario 12 de Octubre (Madrid, 2014)
• Design and implementation of a one-step hematuria clinic, Oncological Urology Unit, Department of Urology, Hospital Universitario 12 de Octubre (Madrid, 2017)

6. Investigation:

• Sub-Investigator in more than 25 phase I-II-III-IV clinical trials
• Principal Investigator in the following trials:
  • CA209-7G8: A phase 3, randomized, double-blind trial of nivolumab in combination with intravesical BCG versus standard of care BCG alone in participants with high-risk non-muscle invasive bladder cancer that is persistent or recurrent after treatment with BCG. NCT04149574
  • THOR-2: A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGFR Mutations or Fusions. NCT04172675
  • BladderGATE: Phase Ib trial of Atezolizumab and BCG in high risk BCG naïve non-muscle invasive bladder cancer (NMIBC) patients. NCT04134000
  • HIVEC HR: use of chemohyperthermia with intravesical mitomycin C (HIVEC) for the treatment of patients with NMIBC and high risk (HR). EudraCT Number 2016-001186-85
  • Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) (MERECA). NCT02432846
  • Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer (POTOMAC). NCT03528694
  • A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder (CA209-9UT). NCT03519256
  • Safety and Tolerability of TAR-200 in Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit for Radical Cystectomy (TAR-200-103). NCT03404791
  • Phase I trial of Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE). NCT04134000
  • Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guérin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST). NCT04165317
  • A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC). NCT04172675
  • A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy (SunRISe-1). NCT04640623

7. Publications:

Publication scores:

• ResearchGate score: 34.47.
• H-index: 10.
• Google Scholar total citations: 466.

*Invited participant having completed a two-round Delphi survey for this paper: Teoh JY, MacLennan S, Chan VW, Miki J, Lee HY, Chiong E, et al. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting. Eur Urol. 2020;78(4):546-69.

AS FIRST OR LAST AUTHOR

• González-Padilla DA, Subiela JD, González-Díaz A, Hernández-Arroyo M, García-Rojo E, Aumatell J, Burgos Revilla J, Rodríguez-Antolín A, Guerrero-Ramos F. Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center. Urol Oncol. 2022 Apr 14:S1078-1439(22)00067-9. doi: 10.1016/j.urolonc.2022.02.018. Epub ahead of print. PMID: 35430137.
• Guerrero-Ramos F, González-Padilla DA, González-Díaz A, de la Rosa-Kehrmann F, Rodríguez-Antolín A, Inman BA, Villacampa-Aubá F. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial. World J Urol. 2022 Jan 17 doi: 10.1007/s00345-022-03928-1. 
• Plata A, Guerrero-Ramos F*, Garcia C, González-Díaz A, Gonzalez-Valcárcel I, de la Morena JM, Díaz-Goizueta FJ, Del Álamo JF, Gonzalo V, Montero J, Sousa-Escandón A, León J, Pontones JL, Delgado F, Adriazola M, Pascual Á, Calleja J, Ruano A, Martínez-Piñeiro L, Angulo JC. Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain. J Clin Med. 2021 Oct 30;10(21):5105. *Both authors contributed equally to the study.
• Álvarez-Maestro M, Guerrero-Ramos F*, Rodríguez-Faba O, Domínguez-Escrig JL, Fernández-Gómez JM. Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC). Actas Urol Esp. 2021 Mar;45(2):93-102. *Both authors contributed equally to the study.
• Guerrero-Ramos F, Rodríguez-Antolín A. New endovesical chemotherapy and means of administration: EMDA, HIVEC, Synergo, Unithermia. Arch Esp Urol. 2020;73(10):934-944.
• Gómez Del Cañizo C, Rodríguez-Izquierdo Jiménez M, Peña Vallejo E, Duarte Ojeda JM, de la Rosa Kehrman F, Rodríguez Antolín A, Guerrero Ramos F. New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives.  Actas Urol Esp. 2020 Nov;44(9):574-585.
• García Rojo E, González Padilla DA, Castelo Loureiro A, Parrilla Rubio L, Tejido Sánchez Á, Guerrero Ramos F. New case of secondary bladder amyloidosis with massive hematuria-role of intravesical instillations with dimethyl sulfoxide. Transl Androl Urol. 2019 Oct;8(5):548-555.
• González-Padilla DA, González-Díaz A, García-Gómez B, Villacampa-Aubá F, Miranda-Utrera N, Rodríguez-Antolín A, Guerrero-Ramos F. Cystoscopy real-time self-visualization and its impact in patient’s pain perception. J Endourol. 2019 Apr;33(4):309-313.
• Molina M*, Guerrero-Ramos F*, Fernández-Ruiz M, González E, Cabrera J, Morales E, Gutierrez E, Hernández E, Polanco N, Hernández A, Praga M, Rodriguez-Antolín A, Pamplona M, de la Rosa F, Cavero T, Chico M, Villar A, Justo I, Andrés A. Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death. Am J Transplant. 2019 Feb;19(2):434-447. Both authors contributed equally to the study.
• Guerrero-Ramos F, Castellano-Gauna D, García-Rojo E, Duarte-Ojeda JM, de la Rosa-Kehrmann F, Villacampa-Aubá F. [Mitomycin C HIVEC. Update and results in high risk patients.] Arch Esp Urol. 2018 May;71(4):417-425. Review. Spanish.
• Guerrero-Ramos F, Lara-Isla A, Justo-Quintas J, Duarte-Ojeda JM, de la Rosa-Kehrmann F, Villacampa-Aubá F. Adjuvant intravesical treatment for non-muscle invasive bladder cancer: The importance of the strain and maintenance. Actas Urol Esp. 2017;41(9):590-595.
• Guerrero-Ramos F, Cavero-Escribano T, Rodríguez-Antolín A, Andrés-Belmonte A, Passas-Martínez, Tejido-Sánchez Á. Perigraft fluid collections after kidney transplantation: Does the type of donor (uncontrolled donation after circulatory death vs. donation after brain death) have a role? Cent European J Urol. 2017;70(4):439-444.
• Felix Guerrero Ramos, Angel Tejido Sanchez, Lucia Garcia Gonzalez, Estibaliz Jimenez Alcaide, Irma Amparo Ospina Galeano, Ana Arrebola Pajares, Jose Medina Polo and Rafael Diaz Gonzalez. Exceptional diagnosis of testicular tumour in a patient with paraneoplastic encephalitis. Journal of Clinical Urology. 2014 7(3):214-5.
• Guerrero-Ramos F, Villacampa-Aubá F, Jiménez-Alcaide E, García-González L, Ospina-Galeano IA, de la Rosa-Kehrmann F, Rodríguez-Antolín A, Passas-Martínez J, Díaz-González R. Renal biopsy with 16G needle: A safety study. Actas Urol Esp. 2014;38(9):584-588.
• Guerrero F, Roustan G, Tejerina E. Single reticulohistiocytoma mimicking a keratoacanthoma. Actas Dermosifiliogr. 2008;99(10):828-30.

OTHER PUBLICATIONS

• Carolina Rubio, José Avendaño-Ortiz, Raquel Ruiz-Palomares, Viktoriya Karaivanova, Omaira Alberquilla, Rebeca Sánchez-Domínguez, José Carlos Casalvilla-Dueñas, Karla Montalbán-Hernández, Iris Lodewijk, Marta Rodríguez-Izquierdo, Ester Munera-Maravilla, Sandra P. Nunes, Cristian Suárez-Cabrera, Miriam Pérez-Crespo, Víctor G. Martínez, Lucía Morales, Mercedes Pérez-Escavy, Miguel Alonso-Sánchez, Roberto Lozano-Rodríguez, Francisco J. Cueto, Luis A. Aguirre, Félix Guerrero-Ramos, Jesús M. Paramio, Eduardo López-Collazo and Marta Dueñas. Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells’ Pluripotency in Bladder Cancer. Cancers (Basel). 2022 Jan 7;14(2):287.
• Hongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, Erica On-Ting Chan, William Lay Keat Ong, Qiang Peng, Marco Moschini, Wojciech Krajewski, Benjamin Pradere, Chi-Fai Ng, Dmitry Enikeev, Nikhil Vasdev, Gokhan Ekin, Alejandro Sousa, Juan Leon, Felix Guerrero-Ramos, Wei-Shen Tan, John Kelly, Shahrokh F. Shariat, J. Alfred Witjes, Jeremy Yuen-Chun Teoh. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Front Surg. 2021 Nov 23;8:775527.
• De Sautu De Borbón EC, Guerra Vales JM, Lumbreras Bermejo C, Guerrero Ramos F, Buj Padilla MJ, González de la Aleja J, Morales Conejo M. Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis. Orphanet J Rare Dis. 2021 May 31;16(1):243.
• Rey-Cárdenas M, Guerrero-Ramos F, Gómez de Liaño Lista A, Carretero-González A, Bote H, Herrera-Juárez M, Carril-Ajuria L, Martín-Soberón M, Sepulveda JM, Billalabeitia EG, Castellano D, de Velasco G. Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future. Cancer Treat Rev. 2021 Feb;93:102142. 
• Subiela JD, Rodríguez Faba Ó, Guerrero-Ramos F, Aumatell J, Breda A, Palou J. Carcinoma in situ of the bladder: why is it underdetected? Curr Opin Urol. 2020 May;30(3):392-399.
• de Velasco G, Carril-Ajuria L, Guerrero-Ramos F, Alonso-Gordoa T, Rodríguez-Moreno JF, Carretero A, Martin-Soberon M, de la Rosa-Kehrmann F, Castellano D. A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial. Oncotarget. 2020 Nov;11(47):4457-4462.
• García-Rojo E, Medina-Polo J, Miranda-Utrera N, Abad-López P, Gonzalez-Padilla DA, González-Díaz A, Arrébola-Pajares A, Guerrero-Ramos F, Tejido-Sánchez Á, Rodríguez-Antolín A. Evaluation of health care-associated infections following radical cystectomy.  Actas Urol Esp (Engl Ed). 2020 Nov;44(9):574-585.
• González-Padilla DA, González-Díaz A, Guerrero-Ramos F, Rodríguez-Serrano A, García-Jarabo E, Corona-laPuerta M, Rodríguez-Antolín A, Villacampa-Aubá F. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.  Urol Oncol. 2021 Jan;39(1):76.e9-76.e14.
• Subiela JD, Rodríguez Faba O, Guerrero Ramos F, Vila Reyes H, Pisano F, Breda A, Palou J. Carcinoma In Situ of the Urinary Bladder: A Systematic Review of Current Knowledge Regarding Detection, Treatment, and Outcomes.  Eur Urol Focus. 2020 Jul 15;6(4):674-682.
• Hevia V, Linares-Espinós E, Alonso-Gordoa T, Fernández-Pello S, Guerrero-Ramos F, Mir C, Molina-Cerrillo J, Musquera-Felip M, Rodríguez-Faba Ó, de Velasco G, Gómez-Dos Santos V. Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice. Arch Esp Urol. 2020 Jun;73(5):360-366.
• Subiela JD, Rodríguez Faba Ó, Guerrero Ramos F, Aumatell JH, Breda A, Palou J. Carcinoma in situ of the bladder: why is it underdetected? Curr Opin Urol. 2020 May;30(3):392-399.
• García-Rojo E, Medina-Polo J, Sopeña-Sutil R, Guerrero-Ramos F, García-Gómez B, Aguilar-Gisbert L, García-Álvarez G, Azcutia-Gómez MR, Gómez-Martín F, Molero-García JM, Pereda-Arregui E, Vargas-Machuca Cabañero MC, Villacampa-Aubá F, Tejido Sánchez Á. Analysis of referrals after a synergic work between Primary Care and Urology. Impact of joint protocol implementation and a continuing education program in our healthcare area. Actas Urol Esp. 2019;43(4):176-181. 
• Segovia C, San José-Enériz E, Munera-Maravilla E, Martínez-Fernández M, Garate L, Miranda E, Vilas-Zornoza A, Lodewijk I, Rubio C, Segrelles C, Valcárcel LV, Rabal O, Casares N, Bernardini A, Suarez-Cabrera C, López-Calderón FF, Fortes P, Casado JA, Dueñas M, Villacampa F, Lasarte JJ, Guerrero-Ramos F, de Velasco G, Oyarzabal J, Castellano D, Agirre X, Prósper F, Paramio JM. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression. Nat Med. 2019 Jul;25(7):1073-1081.
• Rubio C, Martínez-Fernández M, Segovia C, Lodewijk I, Suarez-Cabrera C, Segrelles C, López-Calderón F, Munera-Maravilla E, Santos M, Bernardini A, Garcia-Escudero R, Lorz C, Gomez-Rodriguez MJ, De Velasco G, Otero Blas I, Villacampa F, Guerrero-Ramos F, Ruiz S, de la Rosa F, Domínguez-Rodríguez S, Real FX, Malats N, Castellano D, Dueñas M, Paramio JM. Cdk4/6-inhibitor as a novel therapeutic approach for advanced Bladder Cancer independently of RB1 status. Clin Cancer Res. 2019 Jan 1;25(1):390-402.
• Martínez VG, Rubio C, Martínez-Fernández M, Segovia C, López-Calderón F, Garín MI, Teijeira A, Munera-Maravilla E, Varas A, Sacedón R, Guerrero F, Villacampa F, de la Rosa F, Castellano D, López-Collazo E, Paramio JM, Vicente Á, Dueñas M. BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer. Clin Cancer Res. 2017;23(23):7388-7399.
• Sopeña-Sutil R, Silan F, Butron-Vila MT, Guerrero-Ramos F, Lagaron-Comba E, Passas-Martinez J. Multidisciplinary approach to giant paratesticular liposarcoma. Can Urol Assoc J. 2016 Sep-Oct;10(9-10):E316-E319.
• Medina-Polo J, Guerrero-Ramos F, Pérez-Cadavid S, Arrébola-Pajares A, Sopeña-Sutil R, Benítez-Sala R, Jiménez-Alcaide E, García-González L, Alonso-Isa M, Lara-Isla A, Passas-Martínez JB, Tejido-Sánchez A. Community-associated urinary infections requiring hospitalization: Risk factors, microbiological characteristics and patterns of antibiotic resistance. Actas Urol Esp. 2015 Mar;39(2):104-111.
• Sopeña-Sutil R, Tejido-Sanchez A, Galvan-Ortiz de Urbina M, Guerrero-Ramos F, Garcia-Alvarez G, Passas-Martinez JB. Evolución de las derivaciones de atención primaria a urología. Impacto de un protocolo en enfermedad prostática y de atención continuada. Actas Urol Esp. 2015 Jun;39(5)296-302.
• Jiménez-Alcaide E, Medina-Polo J, García-González L, Arrébola-Pajares A, Guerrero-Ramos F, Pérez-Cadavid S, Sopeña-Sutil R, Benítez-Sala R, Alonso-Isa M, Lara-Isla A, Passas-Martínez JB, Tejido-Sánchez Á. Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, microbiological characteristics and patterns of antibiotic resistance. Arch Esp Urol. 2015 Jul-Aug;68(6):541-50.
• Cabezalí Barbancho D, Guerrero Ramos F, López Vázquez F, Aransay Bramtot A, Gómez Fraile A. Laparoscopic approach for Wilms tumor. Surg Laparosc Endosc Percutan Tech. 2014;24(1):22-5.
• Medina-Polo J, Jiménez-Alcaide E, García-González L, Guerrero-Ramos F, Pérez-Cadavid S, Arrébola-Pajares A, Sopeña-Sutil R, Benítez-Salas R, Díaz-González R, Tejido-Sánchez Á. Healthcare-associated infections in a department of urology: incidence and patterns of antibiotic resistance. Scand J Urol. 2014;48(2):203-9.
• Arrebola-Pajares A, Tejido-Sanchez A, Jiménez-Alcaide E, Medina-Polo J, Perez-Cadavid S, Guerrero-Ramos F, Bautista Passas-Martínez J, Díaz-González R. Survey of satisfaction in hospitalized patients at a urology department. Arch Esp Urol. 2014 Sep;67(7):621-627.
• Cabezalí Barbancho D, Guerrero Ramos F, López Vázquez F, Aransay Bramtot A, Gómez Fraile A. Spontaneous bladder perforation in an infant neurogenic bladder: laparoscopic management. Case Rep Urol. 2013;2013:986362.

Miranda Utrera N, Pamplona Casamayor M, Guerrero Ramos F, Leiva Galvis O. Congenital renal arteriovenous malformation: the value of magnetic resonance Imaging for diagnosis and intravascular management. Actas Urol Esp. 2010;34(2):215-217.

8. Book chapters:

AS FIRST/LAST AUTHOR

• F. Guerrero Ramos. Seguimiento de la hiperplasia benigna de próstata (HBP). En F. de la Rosa Kehrmann (coord.): Hiperplasia Benigna de Próstata, un abordaje multidisciplinar. You & Us, 2019 (ISBN: 978-84-120624-9-6). p 67-73.
• F. Guerrero Ramos. Urología infantil. En A. Guijarro, A. Frenck, I. Espada, R. de Cala (eds.): El manual de Puericultura y Pediatría. 9ª edición. Escuela de la Sociedad Española de Puericultura, 2018 (ISBN: 978-84-608-2397-1). p. 397-406.
• F. Guerrero Ramos. Síndrome escrotal agudo. En C. Bibiano Guillén (ed.): Manual de Urgencias. 3ª edición. Grupo Saned, Madrid, 2018 (ISBN: 978-84-978-84-16831-98-2). p 620-625.
• F. Guerrero Ramos. Criptorquidia. En A. Guijarro, A. Frenck, I. Espada, R. de Cala (eds.): El manual de Puericultura y Pediatría. 8ª edición. Escuela de la Sociedad Española de Puericultura, 2015 (ISBN: 978-84-608-2397-1). p. 407-415.
• F. Guerrero Ramos, I. Ospina Galeano, L. García González, Á. Tejido Sánchez. Tumor uretral de etiología poco frecuente. En JM. Cózar, B. Miñana, J. Angulo (eds.): Concurso de casos clínicos para residentes de Urología 2013. Luzán5, Madrid, 2013 (ISBN: 978-84-7989-783-3). p. 254-258.
• F. Guerrero Ramos, L. García González, E. Jiménez Alcaide, I. A. Ospina Galeano, Á. Tejido Sánchez. Varón joven con un cuadro de diplopía y alteraciones del comportamiento. En J. Angulo (ed.): Concurso de casos clínicos para residentes de Urología 2012. Luzán5, Madrid, 2012 (ISBN: 978-84-7989-723-9). p 319-322.

OTHER CHAPTERS

• I. Ospina Galeano, S. Pérez Cadavid, L. Díez Sicilia, F. Guerrero Ramos, F. Villacampa Aubá. Paciente con una masa en el glande y síndrome miccional irritativo. En J. Angulo (ed.): Concurso de casos clínicos para residentes de Urología 2012. Luzán5, Madrid, 2012 (ISBN: 978-84-7989-723-9). p 434-438.
• L. García González, E. Jiménez Alcaide, F. Guerrero Ramos, V. C. Casu, Á. Tejido Sánchez. Varón joven con lumbalgia y edemas en los miembros inferiores. En J. Angulo (ed.): Concurso de casos clínicos para residentes de Urología 2012. Luzán5, Madrid, 2012 (ISBN: 978-84-7989-723-9). p 521-524.
• E. Jiménez Alcaide, L. García González, F. Guerrero Ramos, A. Arrébola Pajares, F. Villacampa Aubá. Varón de 32 años con hematuria y molestias en el hemiescroto derecho. En J. Angulo (ed.): Concurso de casos clínicos para residentes de Urología 2012. Luzán5, Madrid, 2012 (ISBN: 978-84-7989-723-9). p 569-572.
• I. Ospina Galeano, F. Guerrero Ramos, S. Pérez Cadavid, Á. Tejido Sánchez. Metástasis de adenocarcinoma de colon en el cordón espermático. En JM. Cózar, B. Miñana, J. Angulo (eds.): Concurso de casos clínicos para residentes de Urología 2013. Luzán5, Madrid, 2013 (ISBN: 978-84-7989-783-3). p. 413-416.
• L. García González, E. Jiménez Alcaide, F. Guerrero Ramos, F. de la Rosa Kehrmann. Lesión tiroidea en paciente con antecedente de carcinoma de células renales. En JM. Cózar, B. Miñana, J. Angulo (eds.): Concurso de casos clínicos para residentes de Urología 2013. Luzán5, Madrid, 2013 (ISBN: 978-84-7989-783-3). p. 441-444.

9. National congress communications as first/last author:

(Congress communications not being first/last author have not been included)

• 25º Congreso de la SEIQ (Barcelona, 2019): Evaluation of one-stop hematuria clinic in bladder tumour diganosis. P. Abad-López, A. De la Calle-Moreno, F. De la Rosa-Kehrmann, A. Rodríguez-Antolín, F. Guerrero-Ramos
• LXXXIV Congreso Nacional de Urología (Bilbao, 2019): HIVEC HR: quimiohipertermia con mitomicina C vs BCG como tratamiento para Cáncer de Vejiga No músculo-invasivo de Alto riesgo. Resultados preliminares de un ensayo clínico aleatorizado y controlado. González-Padilla Daniel A.; González-Díaz Alejandro; García-Rojo Esther; Hernánez-Arroyo Mario; Santos-Pérez Rocío; Abad-López Pablo; Miranda-Utrera Natalia; Rodríguez-Antolín Alfredo; Guerrero-Ramos Félix
• LXXXIV Congreso Nacional de Urología (Bilbao, 2019): Registro Nacional de Cáncer de Pene (PIEM-AEU/2014/0002). Borque Fernando, A.; Rubio Briones, J.; Esteban Escaño, L.; Gómez Rivas, Juan; Gaya Sopena, Josep Maria; García-Baquero García De Paredes, Rodrigo; Agreda Castañeda, Fernando; Ortiz Vico, Francisco Javier; Amir Nicolau, Balig Fawwaz; Osman Garcia, Ignacio; Gil Martínez, Pedro; Arrabal Martín, Miguel; Gómez-Ferrer Lozano, Álvaro; Campos-Juanatey, Felix; Guerrero Ramos, Félix
• LXXXIII Congreso Nacional de Urología (Gijón, 2018): Resultados de nefrouretrectomía laparoscópica vs abierta en un hospital terciario: ¿está justificada la controversia? Guerrero Ramos, F.; Villacampa Aubá, F.; Miranda Utrera, N.; Duarte Ojeda, J.M.; De La Rosa Kehrmann, F.; Passas Martínez, J.
• LXXXI Congreso Nacional de Urología (Toledo, 2016): Incidencia comparada de complicaciones postoperatorias en 150 trasplantes renales de asistolia no controlada con preservación normotérmica versus 150 trasplantes renales de muerte encefálica. Guerrero Ramos, F.; Cavero Escribano, T.; Rodríguez Antolín, A.; Medina Polo, J.; Tejido Sánchez, A.; Duarte Ojeda, J.M.; de la Rosa Kehrmann, F.; Pamplona Casamayor, M.; Andrés Belmonte, A.; Passas Martínez, J.B.
• LXXVIII Congreso Nacional de Urología (Granada, 2013): Tratamiento del TVNMI con BCG: ¿puedo cambiar de cepa? Guerrero Ramos, F.; Villacampa Aubá, F.; Ospina Galeano, I.A.; Jiménez Alcaide, E.; García González, L.; Díez Sicilia, L.; Medina Polo, J.; Duarte Ojeda, J.M.; de la Rosa Kehrmann, F.; Díaz González, R.
• LXXVIII Congreso Nacional de Urología (Granada, 2013): Influencia de los polimorfismos genéticos en el cáncer renal en tratamiento con Sunitinib: estudio prospectivo observacional y validación. Guerrero Ramos, F.; Díez Sicilia, L.; Villacampa Aubá, F.; Sepulveda, J.M.; de Velasco, G.; Ospina Galeano, I.A.; García Gómez, B.; Castellano Gauna, D.; de la Rosa Kehrmann, F.; Díaz González, R.
• LXXVII Congreso Nacional de Urología (Vigo, Junio 2012): Análisis prospectivo de polimorfismos genéticos asociados con la toxicidad y supervivencia en pacientes con cáncer renal metastático (CRm) tratados con sunitinib. Guerrero Ramos, F.; Villacampa Aubá, F.; Sepúlveda, J.M.; Ospina Galeano, I.A.; Martínez Silva, V.M.; Duarte Ojeda, J.M.; Castellano Gauna, D.; de la Rosa Kehrmann, F.; Díaz González, R.
• LXXVI Congreso Nacional de Urología (Málaga, Junio 2011): Biopsia renal percutánea: ¿es una técnica segura? Guerrero Ramos, F.; Villacampa Aubá, F.; Jiménez Alcaide, E.; Almonacid Grunert, J.; Ospina Galeano, I.A.; Domínguez Esteban, M.; Miranda Utrera, N.; García González, L.; Medina Polo, J.; Tejido Sánchez, A.; Rodríguez Antolín, A.; Passas Martínez, J.; Díaz González, R.; de la Rosa Kehrmann, F.
• 14º Congreso de la Sociedad Urológica Madrileña (Ávila, Mayo 2013): Análisis prospectivo de polimorfismos genéticos asociados con la toxicidad y supervivencia en pacientes con cáncer renal metastático tratados con sunitinib. Guerrero Ramos F, Villacampa Aubá F, Ospina Galeano I, Díez Sicilia L, García González L, Jiménez Alcaide E, de la Rosa Kehrman F, Díaz González R.
• 13º Congreso de la Sociedad Urológica Madrileña (Sigüenza, Mayo 2012): Biopsia renal percutánea: ¿es una técnica segura? F Guerrero Ramos, I Ospina Galeano, L García González, E Jiménez Alcaide, A Arrébola Pajares, S Pérez Cadavid, F Villacampa Aubá, R Díaz González.
• 12º Congreso de la Sociedad Urológica Madrileña (Cuenca, Mayo 2011): Diagnóstico excepcional de tumor testicular en paciente con encefalitis paraneoplásica. Guerrero Ramos F, Miranda Utrera N, Díaz Díaz D, Medina Polo J, Passas Martínez J, Tejido Sánchez A, Martínez de Aragón A, Usera Sarraga G, Díaz González R.

10. International congress communications as first/last author

(Congress communications not being first/last author have not been included)

• AUA 2020 Annual Meeting (online): BCG vs chemohyperthermia with mitomycin C for high-risk non-muscle invasive bladder carcinoma: preliminary results of HIVEC-HR randomized clinical trial. Felix Guerrero-Ramos, Daniel Antonio Gonzalez-Padilla, Alejandro Gonzalez-Diaz, Felipe Villacampa-Auba, Marta Rodriguez-Izquierdo, Carmen Gomez-Cañizo, Federico de la Rosa-Kehrmann, Alfredo Rodriguez-Antolin (podium session)
• AUA 2020 Annual Meeting (online): IL-10 and CXCL10 urine quantification as useful biomarkers to predict BCG response in bladder cancer patients. Felix Guerrero-Ramos*, Pablo Abad-Lopez, Cristian Suarez-Cabrera, Marta Rodriguez-Izquierdo, Carmen Gomez-Cañizo, Federico de la Rosa-Kehrmann, Victor Garcia-Martinez, Alejandra Bernardini, Iris Lodewijk, Guillermo Paramio, Alfredo Rodriguez-Antolin, Jesus M Paramio, Marta Dueñas.
• AUA 2019 Annual Meeting (Chicago, 2019): BCG VS CHEMOHYPERTHERMIA WITH MITOMYCIN C FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CARCINOMA: PRELIMINARY RESULTS OF HIVEC-HR RANDOMIZED CLINICAL TRIAL. Félix Guerrero-Ramos*, Daniel Antonio González-Padilla, Alejandro González-Díaz, José Manuel Duarte-Ojeda, Natalia Miranda-Utrera, Felipe Villacampa-Aubá, Federico de la Rosa-Kehrmann.
• EAU 2019 (Barcelona, Spain): HIVEC HR: Chemohyperthermia with mitomycin C vs BCG for high-risk non-muscle invasive bladder cancer. Preliminary results from a randomized controlled trial. González Padilla DA, Miranda-Utrera N, de la Rosa Kehrmann F, Villacampa-Aubá F, Guerrero-Ramos F.
• EAU 2019 (Barcelona, Spain): Anti-CD20 and mTOR inhibitors: Can we change the prognosis of post-transplant lymphoproliferative disorder? Guerrero Ramos F, Cavero Escribano T, Pamplona Casamayor M, Rodríguez Antolín A, Duarte Ojeda J, Tejido Sánchez A, Villacampa Aubá F, Medina Polo J, González Monte E, Passas Martínez J, de la Rosa Kehrmann F.
• BLADDR 2018, Global Congress on Bladder Cancer (Madrid): BCG vs chemohyperthermia with mitomycin C for high-risk non-muscle invasive bladder carcinoma: preliminary results of HIVEC-HR randomized clinical trial. F. Guerrero-Ramos, D.A. González-Padilla, A. González-Díaz, F. Villacampa-Aubá, N. Miranda-Utrera, J.M. Duarte-Ojeda, F. de la Rosa-Kehrmann
• 27th International Congress of The Transplantation Society (Madrid, 2018): Survival analysis of kidney transplants with grafts from uncontrolled DCD donors under normothermic preservation prior to organ retrieval related to DBD: Data from our 300 transplants series. Felix Guerrero-Ramos, Teresa Cavero-Escribano, Alfredo Rodriguez-Antolin, Federico de la Rosa-Kehrmann, Manuel Pamplona- Casamayor, Jose Manuel Duarte-Ojeda, Angel Tejido-Sanchez, Felipe Villacampa-Auba, Jose Medina-Polo, Amado Andres- Belmonte, Juan Passas-Martinez
• 27th International Congress of The Transplantation Society (Madrid, 2018): Comparative analyisis of postoperative complications after kidney transplantation: Uncontrolled DCD vs DBD grafts, are they the same? Felix Guerrero-Ramos, Teresa Cavero-Escribano, Alfredo Rodriguez-Antolin, Federico de la Rosa-Kehrmann, Manuel Pamplona- Casamayor, Jose Manuel Duarte-Ojeda, Angel Tejido-Sanchez, Felipe Villacampa-Auba, Jose Medina-Polo, Juan Passas-Martinez, Amado Andres-Belmonte
• 111e Congrès Français d’Urologie (Paris, 2017): La survie des transplantations rénales des donneurs à cœur non-battant incontrôlés sous la protection normothermique : sont-ils aussi bons que les reins des donneurs à cœur battant ? F. Guerrero-Ramos, T. Cavero-Escribano,
F. de la Rosa-Kehrmann, A. Rodríguez-Antolín, M. Pamplona-Casamayor, J. Duarte-Ojeda,
Á. Tejido-Sánchez, F. Villacampa-Aubá,
J. Medina-Polo, A. Andrés-Belmonte,
J. Passas-Martínez
• AUA 2017 Annual Meeting (Boston, USA): Compared incidence of postoperative complications in a series of 150 uncontrolled DCD versus 150 DBD kidney transplants.Félix Guerrero Ramos, Teresa Cavero Escribano, Alfredo Rodríguez Antolín, Manuel Pamplona Casamayor, José Medina Polo, Angel Tejido Sánchez, Federico de la Rosa Kehrmann, José Manuel Duarte Ojeda, Felipe Villacampa Aubá, Amado Andrés Belmonte, Juan Passas Martínez
• AUA 2017 Annual Meeting (Boston, USA): Survival of kidney transplants from uncontrolled DCD donors under normothermic preservation: are they as good as DBD kidneys? Félix Guerrero Ramos, Teresa Cavero Escribano, Angel Tejido Sánchez, Alfredo Rodríguez Antolín, Manuel Pamplona Casamayor, José Medina Polo, Federico de la Rosa Kehrmann, José Manuel Duarte Ojeda, Felipe Villacampa Aubá, Amado Andrés Belmonte, Juan Passas Martínez
• AUA 2017 Annual Meeting (Boston, USA): Survival analysis of patients with muscle invasive bladder cancer not suitable for treatment with a curative intent. Félix Guerrero Ramos, Santiago Pérez Cadavid, Angel Tejido Sánchez, Esther García Rojo, Daniel Antonio González Padilla, Raquel Sopeña Sutil, Felipe Villacampa Aubá, José Manuel Duarte Ojeda, Federico de la Rosa Kehrmann
• EAU 2016 (Munich, Germany): Survival of kidney transplants from uncontrolled DCD donors under normothermic preservation: are they as good as DBD kidneys? Guerrero Ramos F, Cavero Escribano T, Rodríguez Antolín A, Pamplona Casamayor M, Tejido Sánchez A, de la Rosa Kehrmann F, Villacampa Aubá F, Medina Polo J, Andrés Belmonte A, Passas Martínez JB
• EAU 2014 (Stockholm, Sweden): How do genetic polymorphisms influence in sunitinib treated metastatic renal carcinoma? A prospective observational study and validation. F Guerrero Ramos, F Villacampa Aubá, IA Ospina Galeano, JM Sepúlveda Sánchez, D Castellano Gauna, L García González, E Jiménez Alcaide, JM Duarte Ojeda, F de la Rosa Kehrmann, J Passas Martínez, R Díaz González

11. Prizes and grants:

• May 2012: Study Extension Grant for a 6-week stay at University College of London Hospital (Madrid Society of Urology)
• June 2012: First prize of the “National clinical case contest for Urology residents” (Spanish Association of Urology)
• March 2014: Finalist at “V Rising Stars in Urology” (Spanish Association of Urology, Granada, Spain)
• July 2015: grant to attend ESU-Weill Cornell Masterclass in General Urology (American Austrian Foundation, Salzburg, Austria)
• June 2016: 2^nd prize from the journal “Actas Urológicas Españolas” for the article entitled Community-associated urinary infections requiring hospitalization: Risk factors, microbiological characteristics and patterns of antibiotic resistance (Actas Urol Esp. 2015 Mar;39(2):104-111)
• June 2016: 2^nd prize from the journal “Archivos Españoles de Urología” for the article entitled Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, microbiological characteristics and patterns of antibiotic resistance (Arch Esp Urol. 2015 Jul-Aug;68(6):541-50)
• March 2020: 3^rd prize from “HealthStart Madri+d” for the design of a microRNA based diagnostic test for bladder cancer (BlaDimiR), along with the “Genitourinary Tumor Investigation Group” from CIEMAT

12. Professional memberships:

• Sociedad Urológica Madrileña (SUM)
• Asociación Española de Urología (AEU)
• European Urological Association (EAU)
• Fundación OncoSur
• Grupo Centro de Tumores Genitourinarios

---

Ponente en los siguientes cursos:

• II Curso de especialización en Cáncer Renal y Cáncer de Vejiga.
• Curso de especialización Cáncer Renal y Cáncer de Vejiga.